January 26, 2022 Immunocore (IMCR) Gains FDA Approval For Tebentafusp In Uveal Melanoma; SanaCurrents Closing Coverage This content is for members only
September 5, 2021 Immunocore Holdings plc (IMCR) Probability Sentiment This content is for members only